New Anti-Flu Weapon Said to Help Those 65 and Older

February 24, 2020

Seqirus announced today that the US Food and Drug Administration (FDA) has approved Fluad Quadrivalent, touted as the first and only adjuvanted quadrivalent influenza vaccine, developed to help protect adults 65 years and older against seasonal influenza.

First H5N1 Influenza Vaccine Approved by FDA

February 3, 2020

An adjuvanted influenza A H5N1 monovalent vaccine (Audenz) has been approved by the US Food and Drug Administration (FDA). The approval was granted to Seqirus.